TY - JOUR
T1 - Identification, causation, alleviation, and prevention of complications (ICAP)
T2 - an approach to symptom and disability management in multiple sclerosis.
AU - Cohen, Bruce A.
N1 - Funding Information:
Disclosure: Sources of Funding for Research: BioMS Medical Corp.; EMD Serono, Inc.; Novartis Pharmaceuticals Corp; Pfizer Inc. Consulting Agreements: Bayer HealthCare Pharmaceuticals; Biogen Idec; EMD Serono, Inc.; Pfizer Inc.; Teva Neurosciences, Inc. Speakers’ Bureau/Honorarium Agreements: Bayer HealthCare Pharmaceuticals; Biogen Idec; EMD Serono, Inc.; Teva Neurosciences, Inc. Financial Interests/Stock Ownership: Abbott Laboratories.
PY - 2008/12/9
Y1 - 2008/12/9
N2 - Comprehensive management of patients with multiple sclerosis (MS) includes treatment to modify the disease course and interventions to address the persistent symptoms and consequences of this chronic illness, which can affect patients for decades. Although much excitement and attention accompanies new therapeutic initiatives for disease management, symptomatic issues are often overshadowed despite their impact on patients' daily lives. This article describes the application of an organizational scheme of identification, causation, alleviation, and prevention of complications as a tool for identifying and managing symptomatic issues in patients with MS.
AB - Comprehensive management of patients with multiple sclerosis (MS) includes treatment to modify the disease course and interventions to address the persistent symptoms and consequences of this chronic illness, which can affect patients for decades. Although much excitement and attention accompanies new therapeutic initiatives for disease management, symptomatic issues are often overshadowed despite their impact on patients' daily lives. This article describes the application of an organizational scheme of identification, causation, alleviation, and prevention of complications as a tool for identifying and managing symptomatic issues in patients with MS.
UR - http://www.scopus.com/inward/record.url?scp=58149330651&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=58149330651&partnerID=8YFLogxK
U2 - 10.1212/wnl.0b013e31818f3da5
DO - 10.1212/wnl.0b013e31818f3da5
M3 - Article
C2 - 19064870
AN - SCOPUS:58149330651
VL - 71
SP - S14-20
JO - Neurology
JF - Neurology
SN - 0028-3878
IS - 24 Suppl 3
ER -